T. Rowe Price — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Avalyn Pharma develops inhaled therapies for pulmonary fibrosis, using a nebulization approach that delivers treatment directly to the lungs to reduce the tolerability problems of existing oral therapies.
BiotechHealthtech
Lyn Baranowski(CEO)in
Co-investorsAndera PartnersCatalio Capital Management, LPF-Prime CapitalInVivium CapitalNorwest Venture PartnersRiverVest Venture Partners+7 more
Convoy builds webhooks infrastructure for developers and engineering teams to handle event-driven communication at scale.
Cloud ComputingData & InfrastructureDeveloper ToolsEnterprise SoftwareSaaSLondon, GB
Subomi Oluwalana(Co-founder & CEO)in
Co-investorsY CombinatorBaillie GiffordGeneration Investment ManagementMusha VenturesVentures Platform
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.